Total Payments
$109,293
2024 Payments
$12,353
Companies
24
Transactions
146
Medicare Patients
3,053
Medicare Billing
$234,210
Payment Breakdown by Category
Consulting$70,899 (64.9%)
Other$24,591 (22.5%)
Travel$7,015 (6.4%)
Food & Beverage$6,757 (6.2%)
Education$31.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $70,899 | 20 | 64.9% |
| Honoraria | $16,120 | 6 | 14.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,471 | 7 | 7.8% |
| Travel and Lodging | $7,015 | 21 | 6.4% |
| Food and Beverage | $6,757 | 91 | 6.2% |
| Education | $31.50 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Helsinn Healthcare SA | $36,194 | 17 | $0 (2022) |
| Kyowa Kirin, Inc. | $30,847 | 41 | $0 (2024) |
| Helsinn Therapeutics (U.S.), Inc. | $14,103 | 19 | $0 (2024) |
| Almirall LLC | $4,550 | 1 | $0 (2021) |
| Stemline Therapeutics Inc. | $4,270 | 8 | $0 (2021) |
| Celgene Corporation | $4,053 | 18 | $0 (2019) |
| Seattle Genetics, Inc. | $3,572 | 11 | $0 (2019) |
| Kyowa Kirin Services Ltd | $3,400 | 2 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $2,820 | 1 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $2,273 | 3 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,353 | 18 | Kyowa Kirin, Inc. ($12,098) |
| 2023 | $1,977 | 19 | Kyowa Kirin, Inc. ($1,230) |
| 2022 | $16,800 | 13 | Helsinn Healthcare SA ($9,215) |
| 2021 | $27,026 | 19 | Helsinn Healthcare SA ($12,312) |
| 2020 | $9,613 | 4 | Helsinn Healthcare SA ($4,613) |
| 2019 | $22,401 | 30 | Helsinn Healthcare SA ($10,054) |
| 2018 | $1,658 | 15 | Kyowa Kirin Services Ltd ($900.00) |
| 2017 | $17,465 | 28 | Kyowa Kirin, Inc. ($7,289) |
All Payment Transactions
146 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $137.23 | General |
| Category: Monoclonal Antibody | ||||||
| 12/06/2024 | PFIZER INC. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $74.57 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Consulting Fee | Cash or cash equivalent | $3,800.00 | General |
| Category: Monoclonal antibody | ||||||
| 10/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Travel and Lodging | In-kind items and services | $373.31 | General |
| Category: Monoclonal antibody | ||||||
| 10/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $111.10 | General |
| Category: Monoclonal antibody | ||||||
| 08/14/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $72.14 | General |
| Category: Monoclonal Antibody | ||||||
| 07/17/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $109.26 | General |
| Category: Monoclonal Antibody | ||||||
| 05/15/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ONCOLOGY | ||||||
| 03/28/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Consulting Fee | Cash or cash equivalent | $5,040.00 | General |
| Category: Monoclonal Antibody | ||||||
| 03/27/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ONCOLOGY | ||||||
| 03/08/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $93.71 | General |
| Category: Monoclonal Antibody | ||||||
| 03/06/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $78.36 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $36.10 | General |
| Category: Monoclonal Antibody | ||||||
| 02/21/2024 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 01/24/2024 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| Category: Monoclonal Antibody | ||||||
| 12/08/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Oncology | ||||||
| 12/08/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $108.82 | General |
| Category: Oncology | ||||||
| 12/07/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $114.63 | General |
| Category: Monoclonal antibody | ||||||
| 12/07/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $73.02 | General |
| Category: Monoclonal antibody | ||||||
| 12/06/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Travel and Lodging | Cash or cash equivalent | $338.90 | General |
| Category: Monoclonal antibody | ||||||
| 10/26/2023 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $108.26 | General |
| Category: Monoclonal Antibody | ||||||
| 10/04/2023 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 952 | 1,704 | $305,206 | $66,992 |
| 2022 | 15 | 680 | 1,230 | $203,082 | $53,569 |
| 2021 | 15 | 712 | 1,393 | $233,882 | $58,330 |
| 2020 | 11 | 709 | 1,491 | $245,852 | $55,319 |
Total Patients
3,053
Total Services
5,818
Medicare Billing
$234,210
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 64 | 173 | $44,288 | $13,740 | 31.0% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 255 | 404 | $105,848 | $12,104 | 11.4% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 113 | 511 | $52,546 | $11,964 | 22.8% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2023 | 118 | 121 | $23,232 | $8,066 | 34.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 133 | 152 | $19,304 | $4,388 | 22.7% |
| 88323 | Surgical pathology consultation and report on referred material requiring preparation of slides | Facility | 2023 | 47 | 51 | $9,945 | $3,728 | 37.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 26 | $9,880 | $3,130 | 31.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 18 | 18 | $10,026 | $2,731 | 27.2% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 30 | 46 | $6,974 | $1,602 | 23.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $5,412 | $1,291 | 23.8% |
| 11104 | Punch biopsy, first skin growth | Facility | 2023 | 28 | 31 | $4,843 | $1,224 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 18 | 18 | $3,006 | $830.55 | 27.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 14 | 17 | $2,992 | $773.46 | 25.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 16 | 32 | $3,082 | $708.04 | 23.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 61 | 68 | $2,652 | $671.23 | 25.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 11 | 24 | $1,176 | $41.76 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 83 | 242 | $61,952 | $19,933 | 32.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 81 | 318 | $20,568 | $7,592 | 36.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 122 | 178 | $46,636 | $5,495 | 11.8% |
| 88323 | Surgical pathology consultation and report on referred material requiring preparation of slides | Facility | 2022 | 45 | 47 | $9,165 | $3,480 | 38.0% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Facility | 2022 | 46 | 48 | $9,216 | $3,350 | 36.3% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 91 | 104 | $13,208 | $3,047 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 35 | 39 | $6,513 | $2,170 | 33.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 13 | 13 | $7,241 | $1,880 | 26.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $7,216 | $1,816 | 25.2% |
About Christiane Querfeld, MD, PHD
Christiane Querfeld, MD, PHD is a Dermatology healthcare provider based in Duarte, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1467772533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christiane Querfeld, MD, PHD has received a total of $109,293 in payments from pharmaceutical and medical device companies, with $12,353 received in 2024. These payments were reported across 146 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($70,899).
As a Medicare-enrolled provider, Querfeld has provided services to 3,053 Medicare beneficiaries, totaling 5,818 services with total Medicare billing of $234,210. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Dermatopathology
- Location Duarte, CA
- Active Since 06/10/2010
- Last Updated 06/27/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467772533
Products in Payments
- VALCHLOR (Drug) $50,297
- Poteligeo (Drug) $13,328
- SANCUSO (Drug) $8,000
- POTELIGEO (Drug) $7,730
- ELZONRIS (Drug) $4,270
- SGN35 (Biological) $3,353
- Istodax (Drug) $3,346
- CELLEX (Device) $2,820
- CELLEX/XTS PHOTOPHERESIS SYSTEM (Device) $1,130
- Revlimid (Drug) $512.67
- ADCETRIS (Biological) $303.13
- Pomalyst (Drug) $180.16
- BRUKINSA (Drug) $170.92
- CALQUENCE (Drug) $155.32
- Epkinly (Drug) $138.67
- MONJUVI (Drug) $137.76
- IMBRUVICA (Drug) $134.86
- Yescarta (Drug) $119.58
- FOLOTYN (Drug) $114.54
- VALCHLOR MECHLORETHAMINE (Drug) $114.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.